Skip to content
healthcare.dev

Reese Headache Powders

NDC 10956-501, Aspirin and Caffeine, powder, from Reese Pharmaceutical Co.

Product NDC
10956-501
Status
Listed
Labeler
Reese Pharmaceutical Co
Dosage form
POWDER
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10956-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAFFEINE65 mg/1
  • ASPIRIN845 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]

Package NDCNDC-11Package
10956-501-181095605011818 PACKET in 1 CARTON (10956-501-18) / 1 POWDER in 1 PACKET
10956-501-241095605012424 PACKET in 1 CARTON (10956-501-24) / 1 POWDER in 1 PACKET
10956-501-501095605015050 PACKET in 1 CARTON (10956-501-50) / 1 POWDER in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 10956-501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10956-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10956-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.